Effect of applicator removal from target volume for cervical cancer patients treated with Venezia high-dose-rate brachytherapy applicator

ZhengZheng Xu; Bryan J Traughber; Eleanor Harris; Tarun K Podder

doi:10.5114/jcb.2022.114929

Effect of applicator removal from target volume for cervical cancer patients treated with Venezia high-dose-rate brachytherapy applicator

J Contemp Brachytherapy. 2022 Apr;14(2):176-182. doi: 10.5114/jcb.2022.114929. Epub 2022 Mar 24.

Authors

ZhengZheng Xu¹, Bryan J Traughber^{1

2}, Eleanor Harris^{1

2}, Tarun K Podder^{1

2}

Affiliations

¹ Department of Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
² School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Abstract

Purpose: The volume of Venezia applicator with vaginal caps can be relatively large compared to target volumes. This study investigated the dosimetric and radiobiological effects of applicator volume removal for cervical cancer patients treated with Venezia (VZ) and tandem and split-ring (TSR) applicators used in the clinic.

Material and methods: A total of 40 patients (101 plans) with stage IIA-IIIC cervical cancer were retrospectively reviewed. Thirty patients were treated with VZ and ten patients were treated with TSR. Applicators were contoured on planning CTs where target contours were involved. Applicator contours were subtracted from the target contours. External beam radiation therapy (EBRT) and brachytherapy doses were calculated in biologically equivalent doses in 2 Gy fractions (EQD₂) and combined using full parameter addition for dose-volume histogram (DVH) parameters of composited dose. D_90%, D_50%, V_100%, V_150%, V_200%, and tumor control probability (TCP) were evaluated and compared for targets after applicator exclusion.

Results: The average volume changes in gross tumor volume (GTV), high-risk clinical target volume (HR-CTV), and intermediate-risk clinical target volume (IR-CTV) after VZ applicator exclusion were 1.4 ±1.5 cm³, 15.7 ±6.6 cm³, and 33.8 ±15.1 cm³, respectively. VZ exclusion resulted in significant changes (p < 0.05) in small volume parameters (D_50%) and high-dose parameters (V_150% and V_200%) for HR-CTV and IR-CTV. Dosimetric impact of TSR exclusion on targets was not significant. There was no significant change in TCP after applicator exclusion.

Conclusions: Venezia applicator with vaginal caps has significant impact on small volume and high-dose DVH parameters of the target. Applicator contour exclusion is recommended for dosimetric evaluation when Venezia applicator is used.

Keywords: EQD2; HDR brachytherapy; applicator exclusion.